Searchable abstracts of presentations at key conferences in endocrinology

ea0050p026 | Adrenal and Steroids | SFEBES2017

Ipilimumab induced hypophysitis

Okiro Julie , McHugh Catherine

Ipilimumab is an anti-CTLA-4 monoclonal antibody licensed for metastatic melanoma.A 70-year-old female with metastatic malignant melanoma presented with anorexia, malaise and confusion two weeks after her fourth dose of Ipilimumab. She had a low serum sodium of 124 pmol/L on proton pump inhibitor and selective serotonin reuptake inhibitors, which were stopped and she was fluid restricted to 1.5 litres/day. Her urinary sodium wa...

ea0050p026 | Adrenal and Steroids | SFEBES2017

Ipilimumab induced hypophysitis

Okiro Julie , McHugh Catherine

Ipilimumab is an anti-CTLA-4 monoclonal antibody licensed for metastatic melanoma.A 70-year-old female with metastatic malignant melanoma presented with anorexia, malaise and confusion two weeks after her fourth dose of Ipilimumab. She had a low serum sodium of 124 pmol/L on proton pump inhibitor and selective serotonin reuptake inhibitors, which were stopped and she was fluid restricted to 1.5 litres/day. Her urinary sodium wa...

ea0104p81 | Diabetes & Metabolism | SFEIES24

Assessing the prevalence of MASLD in a cohort of patients attending the diabetes clinic in a single centre - using the fibrosis-4 (FIB-4) index for liver fibrosis

Okiro Julie , Ibrahim Ibrahim , Kyne Niamh , Khan Waqar , Vaswani Aneel , McEvoy Robert , Forde Hannah , Smith Diarmuid

The prevalence of Metabolic Associated Steatotic Liver Disease (MASLD) is approximately 55% in patients with Type 2 diabetes (T2DM). The EASL-EASD-EASO guidelines recommend screening patients with T2DM for MASLD. Fibrosis-4 Index (FIB-4) is a simple tool used to screen for MASLD in T2DM. FIB-4 scores are characterised as; low (<1.3), moderate (1.3 – 2.67) or high risk (>2.67). The aim of the audit was to screen a consecutive number of patients attending the out-pa...

ea0081p245 | Late-Breaking | ECE2022

Recalculating renin and aldosterone to improve specificity in the diagnosis of primary aldosteronism

Doyle Luc , Okiro Julie , Sarwani Aysha , Troy Michael , Ansari Yousef , O′Donoghue Darragh , Lappin David , Mcevoy John , O'Shea Paula , Ferguson John , Conall Dennedy Michael

Rationale: The Aldosterone:Renin ratio (ARR) is commonly used for patients fulfilling screening criteria for primary hyperaldosteronism (PA), followed by confirmatory testing. Reference intervals for interpretation of the ARR vary in accordance with local population and assay 1. While ARR provides high sensitivity for PA, this is compromised by low specificity, further compounded by medication interference. However, additional variables may improve the specificity of ARR as a ...

ea0104p148 | Neuroendocrinology | SFEIES24

Effect of endoscopic transsphenoidal surgery on pituitary function – preliminary report from a tertiary referral centre

Okiro Julie , Kyne Niamh , Ibrahim Ibrahim , AlBusaidy Merah , Fuller Raymond , Vaswani Aneel , Carthy Claire , O'Brien Donncha , Zilani Gulam , Javadpour Mohsen , Agha Amar

Limited data are available on the effect of transsphenoidal surgery using the endoscopic method on pituitary function. In this preliminary report we retrospectively evaluated the frequency of pituitary failure and recovery in a population of patients who underwent this procedure over a 12 months period. 42 (21 women) consecutive adult patients were included. 29 patients had non-secretory pituitary neuroendocrine tumours, the rest had secretory tumours and other non-adenomatous...